The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 336:1090-1091 April 10, 1997 Number 15
NextNext

Should PUVA Be Abandoned?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Severe, widespread psoriasis is a devastating skin disease that can disrupt professional, social, and private life. The effectiveness of photochemotherapy with oral methoxsalen (psoralen) and ultraviolet A radiation (PUVA)1 in inducing and maintaining the remission of severe psoriasis has been amply documented1,2 and confirmed in large-scale cooperative clinical trials in both the United States3 and Europe.4 PUVA induces remission of psoriasis through repeated, controlled phototoxic reactions that occur only when psoralens are photoactivated by ultraviolet A. Neither the drug nor ultraviolet A is effective alone.5 Given the penetration characteristics of ultraviolet A, the absorption of photons is confined to the . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.